|
⚲
|
| UBS Equity Opportunity Fund LLC | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001131682 |
| Sale | 2001-03-01 ($77.5 M Sold) |
| Fund | Other Private Fund |
| Phone | 8004862608 |
| Address | 1285 Avenue of The Americas New York, 10019 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2009-12-02 (D/A) |
| Exemption | 506 |
| Minimum | $250,000 |
| Remaining | Indefinite |
| Duration | More than one year |
| Net Assets | Decline to Disclose |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| UBS Fund Advisor LLC | Promoter | |
| Craig Goos | Executive Officer | |
| Stephen Penman | Director | |
| Meyer Feldberg | Director | |
| Virginia Breen | Director | |
| George Gowen | Director | |
| Robert Aufenanger | Executive Officer |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Smith Donald V
✚
|
0.0 | |
|
Smith IKE C
✚
|
0.0 | |
|
Smith Michelle L
✚
|
0.0 | |
|
Smith Randall G
✚
|
0.0 | |
|
Smith Rankin M Jr
✚
|
0.0 | |
|
Smith Richard Robinson
✚
|
0.0 | |
|
Smith Tom E
✚
|
0.0 | |
|
Smosna Christopher A
✚
|
0.0 | |
|
Sofie Biosciences Inc
✚
|
0.0 | |
|
SMG Fund I LLC
✚
|
0.0 |